1. Home
  2. AMZE vs SILO Comparison

AMZE vs SILO Comparison

Compare AMZE & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMZE
  • SILO
  • Stock Information
  • Founded
  • AMZE 2019
  • SILO 2010
  • Country
  • AMZE United States
  • SILO United States
  • Employees
  • AMZE N/A
  • SILO N/A
  • Industry
  • AMZE Beverages (Production/Distribution)
  • SILO Apparel
  • Sector
  • AMZE Consumer Staples
  • SILO Consumer Discretionary
  • Exchange
  • AMZE Nasdaq
  • SILO Nasdaq
  • Market Cap
  • AMZE 8.8M
  • SILO 8.8M
  • IPO Year
  • AMZE 2021
  • SILO N/A
  • Fundamental
  • Price
  • AMZE $0.50
  • SILO $1.16
  • Analyst Decision
  • AMZE
  • SILO
  • Analyst Count
  • AMZE 0
  • SILO 0
  • Target Price
  • AMZE N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • AMZE 171.7K
  • SILO 92.8K
  • Earning Date
  • AMZE 05-13-2025
  • SILO 05-12-2025
  • Dividend Yield
  • AMZE N/A
  • SILO N/A
  • EPS Growth
  • AMZE N/A
  • SILO N/A
  • EPS
  • AMZE N/A
  • SILO N/A
  • Revenue
  • AMZE $299,065.00
  • SILO $72,102.00
  • Revenue This Year
  • AMZE N/A
  • SILO $1.86
  • Revenue Next Year
  • AMZE N/A
  • SILO N/A
  • P/E Ratio
  • AMZE N/A
  • SILO N/A
  • Revenue Growth
  • AMZE N/A
  • SILO N/A
  • 52 Week Low
  • AMZE $0.34
  • SILO $0.77
  • 52 Week High
  • AMZE $0.62
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • AMZE N/A
  • SILO 47.25
  • Support Level
  • AMZE N/A
  • SILO $0.99
  • Resistance Level
  • AMZE N/A
  • SILO $1.19
  • Average True Range (ATR)
  • AMZE 0.00
  • SILO 0.08
  • MACD
  • AMZE 0.00
  • SILO 0.02
  • Stochastic Oscillator
  • AMZE 0.00
  • SILO 75.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: